This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Takeda Vaccines, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Gary Dubin: Innovator in Zika Vaccine Development
Introduction
Gary Dubin is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of vaccine development, particularly focusing on Zika virus vaccines. With a total of 3 patents to his name, Dubin's work is crucial in addressing public health challenges posed by viral infections.
Latest Patents
Among his latest patents, Dubin has developed Zika vaccines and immunogenic compositions. These innovations involve vaccines that contain one or more antigens from the Zika virus, including clonal isolates and non-human cell adapted strains. The methods of treatment and uses of these vaccines are designed to enhance immunity against the Zika virus, showcasing Dubin's commitment to advancing medical science.
Career Highlights
Gary Dubin is currently associated with Takeda Vaccines, Inc., where he continues to push the boundaries of vaccine research. His expertise and innovative approach have positioned him as a key player in the fight against viral diseases.
Collaborations
Throughout his career, Dubin has collaborated with notable colleagues, including Jill Ann Livengood and Hansi Dean. These partnerships have fostered a collaborative environment that enhances the development of effective vaccines.
Conclusion
In summary, Gary Dubin is a dedicated inventor whose work in Zika vaccine development is making a significant impact in the field of immunology. His innovative contributions and collaborations are paving the way for advancements in public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile